Stephen J. Cleland

2.3k total citations
37 papers, 1.7k citations indexed

About

Stephen J. Cleland is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Stephen J. Cleland has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Physiology. Recurrent topics in Stephen J. Cleland's work include Cardiovascular and exercise physiology (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiovascular Health and Disease Prevention (6 papers). Stephen J. Cleland is often cited by papers focused on Cardiovascular and exercise physiology (7 papers), Metabolism, Diabetes, and Cancer (6 papers) and Cardiovascular Health and Disease Prevention (6 papers). Stephen J. Cleland collaborates with scholars based in United Kingdom and Saudi Arabia. Stephen J. Cleland's co-authors include John R. Petrie, Naveed Sattar, John Connell, Henry L. Elliott, Helen M. Colhoun, Nita G. Forouhi, Chris J. Packard, Michael Small, B. M. Fisher and Jason M. R. Gill and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of the American College of Cardiology.

In The Last Decade

Stephen J. Cleland

37 papers receiving 1.7k citations

Peers

Stephen J. Cleland
Laura Schreier Argentina
Elena Henkel Germany
Kum Hyun Han South Korea
Sung Kil Lim South Korea
Laura Schreier Argentina
Stephen J. Cleland
Citations per year, relative to Stephen J. Cleland Stephen J. Cleland (= 1×) peers Laura Schreier

Countries citing papers authored by Stephen J. Cleland

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Cleland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Cleland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Cleland more than expected).

Fields of papers citing papers by Stephen J. Cleland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Cleland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Cleland. The network helps show where Stephen J. Cleland may publish in the future.

Co-authorship network of co-authors of Stephen J. Cleland

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Cleland. A scholar is included among the top collaborators of Stephen J. Cleland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Cleland. Stephen J. Cleland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cleland, Stephen J., et al.. (2014). Endocrine Hypertension. PubMed. 32(2). 268–284. 1 indexed citations
2.
Cleland, Stephen J., B. M. Fisher, Helen M. Colhoun, Naveed Sattar, & John R. Petrie. (2013). Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?. Diabetologia. 56(7). 1462–1470. 167 indexed citations
3.
Newey, Paul, Caroline M. Gorvin, Stephen J. Cleland, et al.. (2013). Mutant Prolactin Receptor and Familial Hyperprolactinemia. New England Journal of Medicine. 369(21). 2012–2020. 77 indexed citations
4.
Moran, Carla, et al.. (2012). Resistance to thyroid hormone – an incidental finding. BMJ Case Reports. 2012. bcr1220115375–bcr1220115375. 3 indexed citations
5.
Livingstone, Shona, Helen C. Looker, Eleanor J. Hothersall, et al.. (2012). Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage Study. PLoS Medicine. 9(10). e1001321–e1001321. 256 indexed citations
6.
Jones, Gregory C., Michael Small, Naveed Sattar, et al.. (2011). AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia. 54(7). 1799–1809. 59 indexed citations
7.
Galloway, Stuart D. R., et al.. (2010). Effects of oral l-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males. Amino Acids. 41(2). 507–515. 22 indexed citations
8.
Boyle, James G., Marie-Ann Ewart, James Reihill, et al.. (2008). Rosiglitazone Stimulates Nitric Oxide Synthesis in Human Aortic Endothelial Cells via AMP-activated Protein Kinase*. Journal of Biological Chemistry. 283(17). 11210–11217. 81 indexed citations
9.
Malkova, Dalia, Colin N. Moran, Stephen J. Cleland, et al.. (2008). Exercise training has greater effects on insulin sensitivity in daughters of patients with type 2 diabetes than in women with no family history of diabetes. Diabetologia. 51(10). 1912–1919. 44 indexed citations
10.
Gill, Jason M. R., Ali Al-Mamari, William R. Ferrell, et al.. (2006). Effect of prior moderate exercise on postprandial metabolism in men with type 2 diabetes: Heterogeneity of responses. Atherosclerosis. 194(1). 134–143. 35 indexed citations
11.
Sattar, Naveed, Stephen J. Cleland, Michael Small, et al.. (2006). Effects of low‐dose continuous combined hormone replacement therapy on glucose homeostasis and markers of cardiovascular risk in women with type 2 diabetes. Clinical Endocrinology. 66(1). 27–34. 29 indexed citations
12.
Cleland, Stephen J., et al.. (2005). Rosiglitazone and phenformin, but not metformin activate AMP-activated protein kinase and stimulate nitric oxide release in human aortic endothelial cells. 1 indexed citations
13.
Gill, Jason M. R., Ali Al-Mamari, William R. Ferrell, et al.. (2005). Effects of a moderate exercise session on postprandial lipoproteins, apolipoproteins and lipoprotein remnants in middle-aged men. Atherosclerosis. 185(1). 87–96. 43 indexed citations
14.
Walters, Mark, et al.. (2004). Cerebral nitric oxide - Mediated vasodilatation is impaired in diabetics. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
15.
Gill, Jason M. R., Ali Al-Mamari, William R. Ferrell, et al.. (2004). Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men. Journal of the American College of Cardiology. 44(12). 2375–2382. 110 indexed citations
16.
Cleland, Stephen J. & Naveed Sattar. (2004). Impact of ethnicity on metabolic disturbance, vascular dysfunction and atherothrombotic cardiovascular disease. Diabetes Obesity and Metabolism. 7(5). 463–470. 14 indexed citations
17.
McCallum, Roland W., John R. Petrie, Michael Small, et al.. (2004). Higher carotid‐radial pulse wave velocity in healthy offspring of patients with Type 2 diabetes. Diabetic Medicine. 21(3). 262–266. 30 indexed citations
18.
Cleland, Stephen J., John R. Petrie, Shinichiro Ueda, Henry L. Elliott, & John Connell. (1999). Insulin-Mediated Vasodilation and Glucose Uptake Are Functionally Linked in Humans. Hypertension. 33(1). 554–558. 58 indexed citations
19.
Cleland, Stephen J., et al.. (1998). The metabolic syndrome: overeating, inactivity, poor compliance or ‘dud’ advice?. Diabetic Medicine. 15(S3). S29–S31. 5 indexed citations
20.
Cleland, Stephen J., et al.. (1996). The renin-angiotensin system and the heart: a historical review. Heart. 76(3 Suppl 3). 7–12. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026